Results 51 to 60 of about 30,809 (165)

Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study

São Paulo Medical Journal
CONTEXT AND OBJECTIVES: Assessment of central blood pressure (BP) has grown substantially over recent years because evidence has shown that central BP is more relevant to cardiovascular outcomes than peripheral BP.
Renan Oliveira Vaz-de-Melo, Luiz Tadeu Giollo-Júnior, Débora Dada Martinelli, Heitor Moreno-Júnior, Marco Antônio Mota-Gomes, José Paulo Cipullo, Juan Carlos Yugar-Toledo, José Fernando Vilela-Martin   +7 more
doaj   +1 more source

Vasodilator agents improve hemodialysis vascular access patency: A population-based study from Korea. [PDF]

Medicine (Baltimore), 2021
Kim DH, Han D, Kim J, Park HC, Lee YK, Shin DG, Kang MK, Cho JR, Choi S, Lee N.   +9 more
europepmc   +1 more source

Automated Cardiac Drug Infusion System Using Adaptive Fuzzy Neural Networks Controller

Biomedical Engineering and Computational Biology, 2011
This paper presents a fuzzy neural network (FNN) control system to automatically manage the hemodynamic variables of patients with hypertension and congestive heart failure (CHF) via simultaneous infusion of cardiac drugs such as vasodilators and ...
Mohamed E. Karar, Mohamed A. El-Brawany
doaj   +1 more source

Endothelin-1 and Nitric Oxide levels in exudative age-related macular degeneration

Journal of Ophthalmic & Vision Research, 2015
Purpose: To evaluate plasma levels of endothelin-1 (ET-1) and nitric oxide (NO) in patients with exudative age-related macular degeneration (AMD). Methods: In this study, ET-1 levels, as well as nitrite plus nitrate concentrations as an indicator of ...
Yuksel Totan, Cemile Koca, Mesut Erdurmuş, Uğurcan Keskin, Ramazan Yiğitoğlu   +4 more
doaj   +1 more source

Effect of amlodipine on the circulating renin‐angiotensin‐aldosterone system in healthy cats

Journal of Veterinary Internal Medicine
Background Systemic hypertension (SH) is a common cardiovascular disease in older cats that is treated primarily with the calcium channel blocker amlodipine besylate (AML).
Tatiana M. Garcia Marrero, Jessica L. Ward, Melissa A. Tropf, Agnes Bourgois‐Mochel, Emilie Guillot, Oliver Domenig, Lingnan Yuan, Debosmita Kundu, Jonathan P. Mochel   +8 more
doaj   +1 more source

Recent Pathophysiological Insights Are Advancing the Treatment of Venous Thromboembolism

JACC: Basic to Translational Science
Summary: Venous thromboembolism, defined as deep vein thrombosis and pulmonary embolism, is the third leading cause of cardiovascular deaths globally. Long-term complications of unresolved venous thrombi include post-thrombotic syndrome in the legs and ...
Satish Singh, PhD, Pardeep Kumar, MSc, Sudesh K. Yadav, PhD, Farouc A. Jaffer, MD, PhD, Guy L. Reed, MD   +4 more
doaj   +1 more source

Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients

International Journal of COPD, 2017
Mariana Muñoz-Esquerre,1 José Luis Ferreiro,2 Daniel Huertas,1,3 Ana Lucrecia Marcano,2 Marta López-Sánchez,1 Gerard Roura,2 Joan Antoni Gómez-Hospital,2 Jordi Dorca,1 Angel Cequier,2 Salud Santos1,3 1Department of ...
Muñoz-Esquerre M, Ferreiro JL, Huertas D, Marcano AL, López-Sánchez M, Roura G, Gómez-Hospital JA, Dorca J, Cequier A, Santos S   +9 more
doaj  

Synthesis of potent vasodilating agents: in silico and in vitro evaluation of 6-(4-substitutedphenyl)-3-pyridazinone derivatives as potential hydralazine analogues

Scientific Reports
People of all age categories and lifestyles suffer to different extents from hypertension. Accordingly, this necessitates the rise of new ways to defeat this enemy.
Marian W. Aziz, Khaled O. Mohamed, Doaa B. Farag, Amira Karam Khalifa, Zeinab Mahmoud   +4 more
doaj   +1 more source

Polyvinylpyrrolidone-coated gold nanoparticles inhibit endothelial cell viability, proliferation, and ERK1/2 phosphorylation and reduce the magnitude of endothelial-independent dilator responses in isolated aortic vessels

International Journal of Nanomedicine, 2017
Teba Mohamed,1,* Sabine Matou-Nasri,2,* Asima Farooq,3 Debra Whitehead,3 May Azzawi1 1School of Healthcare Science, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK; 2Cell and Gene Therapy Group, Medical Genomics ...
Mohamed T, Matou-Nasri S, Farooq A, Whitehead D, Azzawi M   +4 more
doaj  

Vasodilating Agent [PDF]

, 2020
openaire   +1 more source